Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

A GLP-1 oral medication claims to cut the risk of cardiovascular complications, like heart attacks and strokes, by 14% for people with diabetes and heart or kidney disease, per CNBC.

This health news update covers multiple topics including Novo Nordisk's sales expectations, Johnson & Johnson's legal penalty ...

BAGSVAERD, Denmark I March 29, 2025 I Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® ...

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

Dividend King stocks can succumb to management complacency or over conservative policies that can dull a competitive edge, ...

The president has said the levies will be “lenient,” but money managers are on guard given the lack of specifics around what the next package of tariffs may include. In a hint of the potential ...

The War And Treaty’s Michael Trotter, Jr., changed his approach to type 2 diabetes after after being smitten by his wife and ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...

Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...